INTERNATIONAL PATENT: GENENTECH, INC., HOFFMANN-LA ROCHE INC., F. HOFFMANN-LA ROCHE AG FILES APPLICATION FOR "LINEARLY SUBSTITUTED OXAZEPIN-5-ONE KRAS-G12D INHIBITORS"

GENEVA, Sept. 22 -- GENENTECH, INC. (1 DNA WaySouth San Francisco, California 94080-4990), HOFFMANN-LA ROCHE INC. (150 Clove RoadOverlook at Great Notch, Suite 8Little Falls, New Jersey 07424), F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel) filed a patent application (PCT/US2025/020086) for "LINEARLY SUBSTITUTED OXAZEPIN-5-ONE KRAS-G12D INHIBITORS" on Mar 14, 2025. With publication no. WO/2025/194134, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Yong (c/o Genentech, Inc.1 DNA WaySouth San Francisco, Ca...